Arena Pharmaceuticals (ARNA) Upgraded to "Strong-Buy" by BidaskClub


Other equities research analysts have also issued reports about the company. Needham & Company LLC restated a "hold" rating on shares of Arena Pharmaceuticals in a report on Tuesday, August 8th.



from Biotech News